Estadístiques de The McCAVE Trial: vanucizumab plus mFOLFOX-6 versus bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal carcinoma (mCRC)
Visites totals
| views | |
|---|---|
| The McCAVE Trial: vanucizumab plus mFOLFOX-6 versus bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal carcinoma (mCRC) | 68 |
Visites totals per mes
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| bendell-onc-them.pdf | 147 |
| bendell-onc-them.pdf(legacy) | 138 |
Vistes principals per país
| views | |
|---|---|
| United States | 49 |
| Belgium | 5 |
| Spain | 4 |
| India | 3 |
| China | 2 |
| Germany | 2 |
| Iran | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Ann Arbor | 6 |
| Menlo Park | 6 |
| Mountain View | 5 |
| Ashburn | 3 |
| Boardman | 2 |
| San Diego | 2 |
| Shenzhen | 2 |
| Airoli | 1 |
| Alella | 1 |
| Arteixo | 1 |
| Badalona | 1 |
| Bangalore | 1 |
| Cambridge | 1 |
| Fairfield | 1 |
| Fremont | 1 |
| Mumbai | 1 |
| Portland | 1 |
| Redwood City | 1 |
| Shah Alam | 1 |